Scientists have enhanced CRISPR-Cas9 genome editing precision and efficiency by developing DNA-wrapped nanoparticle delivery platforms that increase targeted DNA integration rates in diverse cell types, including non-dividing cells. This hybrid system overcomes key challenges in gene therapy applications by improving repair template delivery and editing predictability, representing a significant step towards safer and more effective therapeutic genome engineering.